Pages that link to "Q37383857"
Jump to navigation
Jump to search
The following pages link to Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene (Q37383857):
Displaying 15 items.
- Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4 (Q33991166) (← links)
- MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells (Q34607094) (← links)
- Genome-wide analysis of alternative splicing in medulloblastoma identifies splicing patterns characteristic of normal cerebellar development. (Q34692925) (← links)
- Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells (Q35552511) (← links)
- miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death (Q36316525) (← links)
- Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand (Q36515448) (← links)
- Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis (Q37193231) (← links)
- IG20/MADD plays a critical role in glucose-induced insulin secretion (Q37715590) (← links)
- DENN Domain Proteins: Regulators of Rab GTPases (Q37844335) (← links)
- Alternative splicing as a biomarker and potential target for drug discovery (Q38527484) (← links)
- The mitochondrial apoptotic pathway is induced by Cu(II) antineoplastic compounds (Casiopeínas®) in SK-N-SH neuroblastoma cells after short exposure times (Q38725601) (← links)
- MADD is a downstream target of PTEN in triggering apoptosis (Q39095766) (← links)
- Potential cytotoxic and amoebicide activity of first row transition metal compounds with 2,9-bis-(2',5'-diazahexanyl)-1,1-phenanthroline (L1). (Q39327176) (← links)
- MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment (Q41843570) (← links)
- Alternative Splicing as a Target for Cancer Treatment. (Q50033988) (← links)